Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Director/PDMR Shareholding

5 Oct 2022 07:00

Arix Bioscience PLC (ARIX)


Director/PDMR Shareholding

05-Oct-2022 / 07:00 GMT/BST

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.


Arix Bioscience plc
("Company")

Director/PDMR Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 100,000 Ordinary shares of 0.001 pence each in the Company (“Shares”) on 4 October 2022 at a price of 102.94 pence per Share.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Peregrine Moncreiffe

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Director and Chair of the Board

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Arix Bioscience plc

b)

 

LEI

 

213800OVT3AHQCXNIX43

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Arix Bioscience plc Ordinary shares of 0.001 pence each

Identification code

GB00BD045071

b)

 

Nature of the transaction

 

Share purchase

  c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

 

102.94

100,000.00

 

d)

 

Aggregated information

 

- Aggregated volume

N/A single transaction

- Price

£102,942.50

e)

 

Date of the transaction

 

04 October 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486



ISIN: GB00BD045071
Category Code: DSH
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 192396
EQS News ID: 1456713

 
End of Announcement EQS News Service


fncls.ssp?fn=show_t_gif&application_id=1456713&application_name=news&site_id=london_south_east
Date   Source Headline
28th May 20214:56 pmEQSTransaction in own shares
27th May 20214:58 pmEQSTransaction in own shares
26th May 20214:53 pmEQSTransaction in own shares
25th May 20215:24 pmEQSTransaction in own shares
24th May 20215:04 pmEQSTransaction in own shares
21st May 20215:09 pmEQSTransaction in own shares
20th May 20215:27 pmEQSTransaction in own shares
20th May 20217:00 amEQSChange of registered office
19th May 20215:06 pmEQSTransaction in own shares
18th May 20215:33 pmEQSTransaction in own shares
18th May 20217:00 amEQSNotice of 2021 Annual General Meeting
17th May 20215:40 pmEQSTransaction in own shares
14th May 20215:02 pmEQSTransaction in own shares
13th May 20215:16 pmEQSTransaction in own shares
12th May 20215:12 pmEQSTransaction in own shares
12th May 20214:35 pmEQSAutolus to present additional data in AUTO1 in IBCL 
11th May 20215:43 pmEQSTransaction in own shares
10th May 20215:21 pmEQSTransaction in own shares
7th May 20215:19 pmEQSTransaction in own shares
6th May 20215:23 pmEQSTransaction in own shares
5th May 20215:16 pmEQSTransaction in own shares
4th May 20215:15 pmEQSTransaction in own shares
4th May 20217:00 amEQSTotal Voting Rights
30th Apr 20214:59 pmEQSTransaction in own shares
30th Apr 20217:00 amEQSOutcome of Strategic Implementation Review and Directorate Change
29th Apr 20215:10 pmEQSTransaction in own shares
28th Apr 20215:14 pmEQSTransaction in own shares
28th Apr 202112:02 pmEQSAmplyx Pharmaceuticals acquired by Pfizer
27th Apr 20215:29 pmEQSTransaction in own shares
27th Apr 20212:00 pmEQSLogicBio announces clinical and corporate updates
26th Apr 20215:32 pmEQSTransaction in own shares
23rd Apr 20215:11 pmEQSTransaction in own shares
22nd Apr 20215:15 pmEQSTransaction in own shares
21st Apr 20215:27 pmEQSTransaction in own shares
20th Apr 20215:31 pmEQSTransaction in own shares
19th Apr 20215:09 pmEQSTransaction in own shares
16th Apr 20215:18 pmEQSTransaction in own shares
15th Apr 20215:09 pmEQSTransaction in own shares
14th Apr 20215:13 pmEQSTransaction in own shares
13th Apr 20215:13 pmEQSTransaction in own shares
12th Apr 20215:23 pmEQSTransaction in own shares
9th Apr 20215:44 pmEQSTransaction in own shares
8th Apr 20215:28 pmEQSTransaction in own shares
8th Apr 20218:19 amRNSProactive One2One Virtual Investor Forum
8th Apr 20217:00 amEQSArix to Present at the Proactive One2One Virtual Investor Forum
7th Apr 20215:47 pmEQSTransaction in own shares
7th Apr 20217:00 amEQSArtios announces collaboration with Novartis to create next generation DDR cancer therapies 
6th Apr 20215:26 pmEQSTransaction in own shares
1st Apr 20215:20 pmEQSTransaction in own shares
1st Apr 20217:00 amEQSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.